FDA Approved: LITHIUM CARBONATE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved Rising Pharma Holdings, Inc.'s original application for lithium carbonate, confirming the generic product's availability for the labeled use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Lithium carbonate (Lithium carbonate)

Snippet

ORIG AP for LITHIUM CARBONATE (LITHIUM CARBONATE)